Advising Comitee

Dr. Martinez cardiologia Dr. Marco Antonio MartínezMéxico.
Dr. Eduarso Souza cardiologia Dr. Eduardo SousaBrasil.
Dr. Pena cardiologia Dr. Irving PeñaVenezuela
Dr. Expedito cardiologia Dr. Expedito RibeiroBrasil.
Dr. Marchant cardiologia Dr. Eugenio MarchantChile.
Dr. Ban Hayashi cardiologia Dr. Ernesto Ban HayashiMéxico.
Dr. Oscar Mendiz Dr. Oscar MendizArgentina
Dr. Suarez cardiologia Dr. Alberto SuárezColombia.
Dr. Londero cardiologia Dr. Hugo LonderoArgentina.
Dr. Berrocal cardiologia Dr. Daniel BerrocalArgentina.
Dr. Belardi cardiologia Dr. Jorge BelardiArgentina.
Dr. Abizaid cardiologia Dr. Alexandre AbizaidBrasil.
Dr. Echeverri cardiologia Dr. Darío EcheverriColombia.
 

 

 

 

Previous article
Next article

More articles by this author

Esta es una entrada en ingles

demo en ingles

test eng

Download the Official SOLACI-CACI 2024 Congress APP

  DOWNLOAD THE OFFICIAL APP OF SOLACI-CACI 2024 Next Wednesday marks the beginning of SOLACI-CACI 2024! Download the Congress APP and discover the unmissable program of the...

Survey on Hemodynamics Centers in Latin America – SOLACI, Stent Save a Life! and South American Society of Cardiology Initiative

The treatment of ST-segment elevation myocardial infarction (STEMI) in Latin America is highly diverse. There are notable differences between countries and even among regions...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...